Transcriptomics

Dataset Information

0

Reactivation of mutant p53 by SLMP53-2: a promising therapeutic option against hepatocellular carcinoma


ABSTRACT: In order to pursue the search for new reactivators of mutant p53, a small library of molecules was synthesized starting from a previously established lead (SLMP53-1). The molecules were tested in various cell-based assays and one, herein referred to as SLMP53-2, displayed a marked reduction of the IC50 values in NCI-H1299 cells expressing the p53 mutants (mutp53) R175H, Y220C, G245S, R248Q, R273C, and R273H. The activity of SLMP53-2 was then investigated using cancer cells lines expressing endogenous mutant p53 and focusing on hepatocellular carcinoma HuH-7 and breast ductal carcinoma HCC1419 cells endogenously expressing mutp53-Y220C. In HuH-7 cells, SLMP53-2 displayed a concentration-dependent growth inhibitory effect on colony formation, restored wt-like p53 protein conformation and transcriptional activity and displayed in vivo antitumour activity in a xenograft mouse model, with no apparent toxicity for normal tissues. To investigate more deeply the impact of SLMP53-2 treatments on gene expression in HuH-7 cells we performed microarray-based analysis using two different concentrations of the compound, corresponding to 2x and 3x IC50. We also employed the MDM2 inhibitor Nutlin alone or in combination with 2x IC50 SLMP53-2.

ORGANISM(S): Homo sapiens

PROVIDER: GSE124021 | GEO | 2020/04/13

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-08-12 | MSV000095580 | MassIVE
2022-08-30 | GSE145482 | GEO
2011-11-02 | E-GEOD-33362 | biostudies-arrayexpress
2012-12-10 | GSE35453 | GEO
2012-12-10 | E-GEOD-35453 | biostudies-arrayexpress
2011-11-02 | GSE33362 | GEO
2012-12-10 | E-GEOD-35454 | biostudies-arrayexpress
2016-11-29 | E-MTAB-4672 | biostudies-arrayexpress
2018-02-07 | GSE110220 | GEO
2012-12-10 | GSE35454 | GEO